Readystate Asset Management’s Verona Pharma VRNA Stock Holding History

Readystate Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-262,265	Closed	-$28M	–	480
2025 Q3	$28M	Buy	262,265 +207,265	+377%	+$21.6M	1.19%	18
2025 Q2	$5.2M	Buy	+55,000	New	+$4.07M	0.16%	102

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Readystate Asset Management's VRNA Position: Q4 2025 in Review

Readystate Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 262,265 shares — an estimated $28M sold.

Readystate Asset Management first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $28M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Readystate Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Readystate Asset Management sold 262,265 Verona Pharma shares in Q4 2025, an estimated $28M.
Readystate Asset Management first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Readystate Asset Management's Verona Pharma position peaked at $28M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Readystate Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.